A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass

Anesthesia and Analgesia

Volumn 106, Issue 2, 2008, Pages 419-425

  Guzzetta, Nina A ^a,b   Bajaj, Tanya ^b   Fazlollah, Tom ^a   Szlam, Fania ^a   Wilson, Elizabeth ^a   Kaiser, Anna ^a   Tosone, Steven R ^a   Miller, Bruce E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Children's Healthcare of Atlanta at Egleston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; BLOOD CLOTTING FACTOR 8; HEPARIN;

ANTICOAGULATION; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DRUG EFFICACY; ELECTIVE SURGERY; HEMOSTASIS; HUMAN; INFANT; PRIORITY JOURNAL; TREATMENT OUTCOME; WARMING;

EID: 38549090023     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000297290.03501.db     Document Type: Article

References (27)

1. Culliford AT, Gitel SN, Starr N, Thomas ST, Baumann FG, Wessler S, Spencer FC. Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass. Ann Surg 1981;193:105-11
2. Despotis GJ, Summerfield AL, Joist JH, Goodnough LT, Santoro SA, Spitznagel E, Cox JL, Lappas DG. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations. J Thorac Cardiovasc Surg 1994;108:1076-82
3. Niles SD, Sutton RG, Ploessl J, Pennell B. Correlation of ACT as measured with three commercially available devices with circulating heparin levels during cardiac surgery. J Extracorporeal Technol 1995;27:197-200
4. Horkay F, Martin P, Saeed W, Rajah SM, Walker DR. Measurement of the activated clotting time (ACT) during cardiopulmonary bypass in children: is it relevant? J Cardiovasc Surg 1991;32(suppl):80
5. Owings JT, Pollock ME, Gosselin RC, Ireland K, Jahr JS, Larkin EC. Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques. Arch Surg 2000;135:1042-7
6. Horkay F, Martin P, Rajah SM, Walker DR. Response to heparinization in adults and children undergoing cardiac operations. Ann Thorac Surg 1992;53:822-6
7. Cohen EG, Camerlengo LJ, Dearing JP. Activated clotting times and cardiopulmonary bypass I: The effect of hemodilution and hypothermia upon activated clotting time. J Extracorporeal Technol 1980;12:139-41
8. McDonald MM, Jacobson LJ, Hay WW, Hathaway WE. Heparin clearance in the newborn. Pediatr Res 1981;15:1015-8
9. Andrew M. Anticoagulation and thrombolysis in children. Texas Heart Institute J 1992;19:168-77
10. Guzzetta NA, Miller BE, Todd K, Szlam F, Moore RH, Tosone SR. An evaluation of the effects of a standard heparin dose on thrombin inhibition during cardiopulmonary bypass in neonates. Anesth Analg 2005;100:1276-82
11. Slaughter TF, LeBleu TH, Douglas JM, Leslie JB, Parker JK, Greenberg CS. Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers. Anesthesiology 1994;80:520-6
12. Weitz JI, Hudoba M, Massel D, Maraganore J, Hirsh J. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest 1990;86:385-91
13. Despotis GJ, Joist JH, Hogue CW, Alsoufiev A, Joiner-Maier D, Santoro SA, Spitznagel E, Weitz JI, Goodnough LT. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT. Thromb Haemost 1996;76:902-8
14. Koster A, Fischer T, Praus M, Haberzettl H, Kuebler WM, Hetzer R, Kuppe H. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management. Anesthesiology 2002;97:837-41
15. Ofosu FA, Fernandez F, Gauthier D, Buchanan MR. Heparin cofactor II and other endogenous factors in the mediation of the antithrombotic and anticoagulant effects of heparin and drematan sulfate. Semin Thromb Hemost 1985;11:133-7
16. Turner-Gomes SO, Nitschmann EP, Norman GR, Andrew ME, Williams WG. Effect of heparin loading during congenital heart operation on thrombin generation and blood loss. Ann Thorac Surg 1997;63:482-8
17. Miller BE, Tosone SR, Guzzetta NA, Miller JL, Brosius KK. Fibrinogen in children undergoing cardiac surgery: is it effective? Anesth Analg 2004;99:1341-6
18. Wachtfogel YT, Kettner C, Hack CE, Nuijens JH, Reilly TM, Knabb RM, Kucich U, Niewiarowski S, Edmunds LH, Colman RW. Thrombin and human plasma kallikrein inhibition during simulated extracorporeal circulation block platelet and neutrophil activation. Thromb Haemost 1998;80:686-91
19. Codispoti M, Ludlam CA, Simpson D, Mankad PS. Individualized heparin and protamine management in infants and children undergoing cardiac operations. Ann Thorac Surg 2001;71:922-7
20. Aldea GS, Soltow LO, Chandler WL, Triggs CM, Vocelka CR, Crockett GI, Shin YT, Curtis WE, Verrier ED. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg 2002;123:742-55
21. Landis RC, Haskard DO, Taylor KM. New anti-inflammatory and platelet-preserving effects of Aprotinin. Ann Thorac Surg 2001;72:S1808-13
22. Sandset PM. Tissue factor pathway inhibitor (TFPI)-an update. Haemostasis 1996;26:154-65
23. Cvirn G, Gallistl S, Leschnik B, Muntean W. Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates. J Thromb Haemost 2003;1:263-8
24. Milam JD, Austin SF, Martin RF, Keats AS, Cooley DA. Alteration of coagulation and selected clinical chemistry parameters in patients undergoing open heart surgery without transfusions. Am J Clin Pathol 1981;76:155-62
25. Mammen EF, Koets MH, Washington BC, Wolk LW, Brown JM, Burdick M, Selik NR, Wilson RF. Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost 1985;11:281-92
26. Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990;12:95-104
27. Lake CL Normal Hemostasis. In: Lake CL, Moore RA, eds. Blood: hemostasis, transfusion, and alternatives in the perioperative period. New York: Raven Press, 1995:3-16